NCT04421937

Brief Summary

In our study, our aim is to evaluate the effect of neuromuscular electrical stimulation added to traditional dysphagia therapy in stroke patients with dysphagia, on functional oral intake status, dysphagia-related symptoms, quality of life, and complications related to dysphagia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
Completed

Started Apr 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 15, 2020

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 16, 2020

Completed
24 days until next milestone

First Posted

Study publicly available on registry

June 9, 2020

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2022

Completed
17 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 16, 2022

Completed
Last Updated

August 23, 2022

Status Verified

August 1, 2022

Enrollment Period

1.8 years

First QC Date

May 16, 2020

Last Update Submit

August 20, 2022

Conditions

Keywords

strokeswallowing disorderdysphagiastroke rehabilitationneuromuscular electrical stimulationtraditional dysphagia therapy

Outcome Measures

Primary Outcomes (1)

  • Change in Functional Oral Intake Scale (FOIS)

    Functional Oral Intake Scale (FOIS) is a scale that shows the functional oral intake of patients with dysphagia. FOIS used for evaluation is a two part scale consisting of 7 levels. It is used to show whether the individual is dependent on the feeding tube and the level of oral intake. On this scale, 7 shows the best and 1 shows the worst functional oral intake. The change in FOIS will be our primary outcome measure in our research. It has been evaluated as an appropriate tool to demonstrate the change in functional oral intake in stroke patients. It is suitable as an independent measure of functional oral intake in prospective studies of stroke-related dysphagia.

    before intervention, immediately after intervention, 3 months after the intervention

Secondary Outcomes (6)

  • Change in Eating Assessment Tool-10 (EAT-10) Score

    before intervention, immediately after intervention, 3 months after the intervention

  • Change in Swallowing-related Quality of Life (SWAL-QOL) Score

    before intervention, immediately after intervention, 3 months after the intervention

  • Change in Visual Analog Scale (VAS)

    before intervention, immediately after intervention, 3 months after the intervention

  • Change in Laryngostroboscopy Examination

    before intervention, immediately after intervention

  • Change in Fiberoptic Endoscopic Evaluation of Swallowing (FEES)

    before intervention, immediately after intervention

  • +1 more secondary outcomes

Study Arms (2)

Neuromuscular Electrical Stimulation (NMES) with TDT

EXPERIMENTAL
Device: Procedure: Neuromuscular Electrical Stimulation with TDT

Traditional Dysphagia Therapy (TDT)

ACTIVE COMPARATOR
Behavioral: Procedure: Traditional Dysphagia Therapy (TDT)

Interventions

Traditional dysphagia therapy includes diet modification training, teaching postural compensatory methods, training of oral motor control exercises and tongue root exercises, training of swallowing maneuvers, and practice of chin-resistance exercise, which is the exercise of opening the upper esophageal sphincter. Traditional Dysphagia Therapy will be applied for 45 minutes a day, 5 days a week for 3 weeks.

Traditional Dysphagia Therapy (TDT)

The skin to be treated will be cleaned and dried. NMES will be implemented with signals received from two channels. In the first channel, the upper electrodes will be placed horizontally just above the hyoid bone. This is the place where the cupping is felt when the finger is pressed right under the chin. In the second channel, the lower electrodes will be placed horizontally, just above the thyrohyoid muscle. This is the place where you can feel a cupping when pressed with your finger, on both sides of the apple in the larynx. The device will be set to start at the lowest power, with very short pulses of approximately 700 microseconds, at intervals of 1 second. The power will be gradually increased according to the device and the power that the patient feels vibration will be stopped. The power to be applied will not exceed 25 milliamps. NMES application and Traditional Dysphagia Therapy will be applied for 45 minutes a day, 5 days a week for 3 weeks.

Neuromuscular Electrical Stimulation (NMES) with TDT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • After the first week after a stroke, detecting dysphagia by using bedside water assessment test
  • Lesion location is shown by MRI or CT
  • Unsupported sitting balance
  • The score of Mini-mental state examination test (MMSE) 20 and above
  • Over 18 years old

You may not qualify if:

  • Global aphasia or cognitive disorders that may affect the understanding of the instructions
  • Patients with major medical problems that may affect participation
  • Tracheostomy presence
  • Previous neck surgery
  • To have received radiotherapy in the head or neck area
  • Presence of a cardiac pacemaker or a history of epilepsy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University Istanbul Faculty of Medicine, Department of Physical Medicine and Rehabilitation

Istanbul, Fatih, 34093, Turkey (Türkiye)

Location

MeSH Terms

Conditions

StrokeDeglutition Disorders

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic Diseases

Study Officials

  • Elif Tarihçi, MD

    Istanbul University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 16, 2020

First Posted

June 9, 2020

Study Start

April 15, 2020

Primary Completion

January 30, 2022

Study Completion

February 16, 2022

Last Updated

August 23, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations